June 27, 2012
by admin
0 comments
DrugBaron is fortunate enough to review hundreds of exciting early-stage drug development projects every year, for organizations as diverse as the British Heart Foundation, Wellcome Trust and US National Institutes of Health as well as Index Ventures and Total Medical … Continue reading
June 19, 2012
by admin
1 Comment
It is inevitable that clinical trials will fail. No matter how good the hypothesis, how promising the compound, sometimes our understanding of the biology was just too patchy. Humans are, after all, complex creatures. But for every “acceptable failure” when … Continue reading